{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:38:03Z","timestamp":1777628283771,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","award":["21278"],"award-info":[{"award-number":["21278"]}],"id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["FNS 324730_144260"],"award-info":[{"award-number":["FNS 324730_144260"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012496","name":"nccr \u2013 on the move","doi-asserted-by":"publisher","award":["51NF40-158776"],"award-info":[{"award-number":["51NF40-158776"]}],"id":[{"id":"10.13039\/100012496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["23234"],"award-info":[{"award-number":["23234"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["2015\\u20130321"],"award-info":[{"award-number":["2015\\u20130321"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009531","name":"Istituto Italiano di Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.neuropharm.2020.107995","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T01:58:22Z","timestamp":1581299902000},"page":"107995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome"],"prefix":"10.1016","volume":"168","author":[{"given":"Marco","family":"Armando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariasole","family":"Ciampoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmela","family":"Padula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Amminger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"De Crescenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maude","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Schaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Manag\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Eliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Papaleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.107995_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neubiorev.2017.09.027","article-title":"Dopamine, the antipsychotic molecule: a perspective on mechanisms underlying antipsychotic response variability","volume":"85","author":"Amato","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2020.107995_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib3","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1038\/ncomms8934","article-title":"Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study","volume":"6","author":"Amminger","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.107995_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/13638490110091347","article-title":"Assessing executive functions in children: biological, psychological, and developmental considerationst","volume":"4","author":"Anderson","year":"2001","journal-title":"Pediatr. Rehabil."},{"key":"10.1016\/j.neuropharm.2020.107995_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/eip.12197","article-title":"Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial","volume":"10","author":"Armando","year":"2016","journal-title":"Early Interv. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2012.04.020","article-title":"Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning","volume":"139","author":"Armando","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2020.107995_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11689-009-9008-9","article-title":"Visuospatial working memory in children and adolescents with 22q11.2 deletion syndrome; an fMRI study","volume":"1","author":"Azuma","year":"2009","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2020.107995_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpeds.2011.02.039","article-title":"Practical guidelines for managing patients with 22q11.2 deletion syndrome","volume":"159","author":"Bassett","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-016-9174-5","article-title":"Visual memory profile in 22q11.2 microdeletion syndrome: are there differences in performance and neurobiological substrates between tasks linked to ventral and dorsal visual brain structures? A cross-sectional and longitudinal study","volume":"8","author":"Bostelmann","year":"2016","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2020.107995_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0022-3956(94)90012-4","article-title":"Schizophrenic individuals' cognitive functioning and performance in interpersonal interactions and skills training procedures","volume":"28","author":"Bowen","year":"1994","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.107995_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/00048670903489882","article-title":"Executive functions and memory abilities in children with 22q11.2 deletion syndrome","volume":"44","author":"Campbell","year":"2010","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib12","article-title":"Treatment response prediction and individualized identification of first-episode drug-na\u00efve schizophrenia using brain functional connectivity","author":"Cao","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/npp.2017.160","article-title":"Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies","volume":"43","author":"Chang","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107995_bib14","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107995_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.schres.2006.04.007","article-title":"Neurocognitive profile in 22q11 deletion syndrome and schizophrenia","volume":"87","author":"Chow","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2020.107995_bib16","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1038\/s41598-017-10112-8","article-title":"Attentional control in adolescent mice assessed with a modified five choice serial reaction time task","volume":"7","author":"Ciampoli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.107995_bib17","series-title":"Conner's Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual","author":"Conners","year":"2000"},{"key":"10.1016\/j.neuropharm.2020.107995_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0269881115587958","article-title":"Omega-3 polyunsaturated fatty acid supplementation and cognition: a systematic review and meta-analysis","volume":"29","author":"Cooper","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib19","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.neuropsychologia.2006.02.006","article-title":"Development of cognitive control and executive functions from 4 to 13 years: evidence from manipulations of memory, inhibition, and task switching","volume":"44","author":"Davidson","year":"2006","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neuropharm.2020.107995_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/wps.20526","article-title":"Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry off","volume":"17","author":"Davies","year":"2018","journal-title":"J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.neuropharm.2020.107995_bib21","first-page":"1","article-title":"[Formula: see text]Executive functioning and its relation to ASD and ADHD symptomatology in 22q11.2 deletion syndrome","volume":"24","author":"de Sonneville","year":"2018","journal-title":"Child Neuropsychol. J. Norm. Abnorm. Dev. Child. Adolesc."},{"key":"10.1016\/j.neuropharm.2020.107995_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.encep.2014.10.005","article-title":"[Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome]","volume":"41","author":"Demily","year":"2015","journal-title":"L\u2019Encephale"},{"key":"10.1016\/j.neuropharm.2020.107995_bib23","series-title":"Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID-I)","author":"First","year":"1996"},{"key":"10.1016\/j.neuropharm.2020.107995_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.1992.tb22843.x","article-title":"P3 and schizophrenia","volume":"658","author":"Ford","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.107995_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1037\/0021-843X.91.5.311","article-title":"Serial recall by schizophrenic and affective patients during and after psychotic episodes","volume":"91","author":"Frame","year":"1982","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/JCP.0b013e318248b7bb","article-title":"Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies","volume":"32","author":"Fusar-Poli","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","article-title":"The psychosis high-risk state: a comprehensive state-of-the-art review","volume":"70","author":"Fusar-Poli","year":"2013","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archpsyc.1990.01810140071010","article-title":"Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence","volume":"47","author":"Grillon","year":"1990","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/schbul\/sbi029","article-title":"Psychological interventions in early psychosis","volume":"31","author":"Haddock","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2020.107995_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1037\/a0023938","article-title":"Visuospatial attention in schizophrenia: deficits in broad monitoring","volume":"121","author":"Hahn","year":"2012","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuroimage.2006.04.177","article-title":"Neuroanatomical dissociation between bottom-up and top-down processes of visuospatial selective attention","volume":"32","author":"Hahn","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2020.107995_bib33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1037\/0021-843X.90.4.298","article-title":"Distractibility in children vulnerable to psychopathology","volume":"90","author":"Harvey","year":"1981","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib34","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00213-017-4611-z","article-title":"A schizophrenia relevant 5-Choice Serial Reaction Time Task for mice assessing broad monitoring, distractibility and impulsivity","volume":"234","author":"Huang","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2020.107995_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.107995_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and Lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107995_bib37","series-title":"Dementia Praecox and Paraphrenia","author":"Kraepelin","year":"1919"},{"key":"10.1016\/j.neuropharm.2020.107995_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.b.30379","article-title":"Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome","volume":"144B","author":"Lewandowski","year":"2007","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2020.107995_bib39","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol","volume":"160","author":"Lieberman","year":"2003","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-016-9141-1","article-title":"Developmental trajectories of executive functions in 22q11.2 deletion syndrome","volume":"8","author":"Maeder","year":"2016","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2020.107995_bib41","doi-asserted-by":"crossref","first-page":"1482.e17","DOI":"10.1016\/j.neurobiolaging.2011.12.014","article-title":"Effects of omega-3 fatty acids on cognitive performance: a meta-analysis","volume":"33","author":"Mazereeuw","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2020.107995_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/1866-1955-6-38","article-title":"Pre-pulse inhibition and antisaccade performance indicate impaired attention modulation of cognitive inhibition in 22q11.2 deletion syndrome (22q11DS)","volume":"6","author":"McCabe","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2020.107995_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/wps.20144","article-title":"Biomarkers and clinical staging in psychiatry. World Psychiatry off","volume":"13","author":"McGorry","year":"2014","journal-title":"J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.neuropharm.2020.107995_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamapsychiatry.2016.2902","article-title":"Effect of \u03c9-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial","volume":"74","author":"McGorry","year":"2017","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(95)92285-7","article-title":"Genetic basis of schizophrenia","volume":"346","author":"McGuffin","year":"1995","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neuropharm.2020.107995_bib46","doi-asserted-by":"crossref","first-page":"18601","DOI":"10.1073\/pnas.1211507109","article-title":"Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome","volume":"109","author":"Meechan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2020.107995_bib47","doi-asserted-by":"crossref","first-page":"16434","DOI":"10.1073\/pnas.0905696106","article-title":"Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion\/DiGeorge syndrome","volume":"106","author":"Meechan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2020.107995_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00406-013-0445-9","article-title":"Common and disease-specific dysfunctions of brain systems underlying attentional and executive control in schizophrenia and bipolar disorder","volume":"264","author":"Melcher","year":"2014","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107995_bib49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(01)00247-1","article-title":"TBX1 is responsible for cardiovascular defects in velo-cardio-facial\/DiGeorge syndrome","volume":"104","author":"Merscher","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.107995_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrd.2016.28","article-title":"Altering the course of schizophrenia: progress and perspectives","volume":"15","author":"Millan","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2020.107995_bib51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/schbul\/sbl042","article-title":"Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk","volume":"33","author":"Morrison","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2020.107995_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ridd.2009.09.001","article-title":"The neuropsychology of 22q11 deletion syndrome. A neuropsychiatric study of 100 individuals","volume":"31","author":"Niklasson","year":"2010","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.neuropharm.2020.107995_bib53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1037\/0021-843X.87.2.212","article-title":"Selective attention in schizophrenic and manic psychoses: the effect of distraction on information processing","volume":"87","author":"Oltmanns","year":"1978","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1037\/h0076721","article-title":"Schizophrenic performance when distractors are present: attentional deficit or differential task difficulty?","volume":"84","author":"Oltmanns","year":"1975","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib55","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.neuropharm.2011.04.025","article-title":"Mouse models of genetic effects on cognition: relevance to schizophrenia","volume":"62","author":"Papaleo","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107995_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nutrit\/nux064","article-title":"Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials","volume":"76","author":"Rangel-Huerta","year":"2018","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.neuropharm.2020.107995_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004583-200001000-00017","article-title":"Diagnostic interview for children and adolescents (DICA)","volume":"39","author":"Reich","year":"2000","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107995_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2020.107995_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1196\/annals.1308.045","article-title":"Cognitive and emotional components of frontal lobe functioning in childhood and adolescence","volume":"1021","author":"Rosso","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.107995_bib60","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41467-018-04711-w","article-title":"Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment","volume":"9","author":"Scheggia","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.107995_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/wps.20347","article-title":"Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome. World Psychiatry off","volume":"15","author":"Schneider","year":"2016","journal-title":"J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.neuropharm.2020.107995_bib62","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2013.13070864","article-title":"Psychiatric disorders from childhood to adulthood in 22q11. 2 deletion syndrome: results from the international consortium on brain and behavior in 22q11. 2 deletion syndrome","author":"Schneider","year":"2014","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psychres.2011.08.017","article-title":"Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome","volume":"196","author":"Schneider","year":"2012","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.107995_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/eip.12224","article-title":"Negative and paranoid symptoms are associated with negative performance beliefs and social cognition in 22q11.2 deletion syndrome","volume":"11","author":"Schneider","year":"2017","journal-title":"Early Interv. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib65","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpsychires.2013.10.010","article-title":"Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome","volume":"48","author":"Schneider","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.107995_bib66","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamapsychiatry.2016.2479","article-title":"Association of neurocognition with transition to psychosis: baseline functioning in the second phase of the north American prodrome longitudinal study","volume":"73","author":"Seidman","year":"2016","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2014.00566","article-title":"The development of cognitive control in children with chromosome 22q11.2 deletion syndrome","volume":"5","author":"Shapiro","year":"2014","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fpsyt.2013.00081","article-title":"A cross-sectional analysis of the development of response inhibition in children with chromosome 22q11.2 deletion syndrome","volume":"4","author":"Shapiro","year":"2013","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib69","article-title":"Age-related changes in distractibility: developmental trajectory of sustained attention in ADHD","author":"Slobodin","year":"2015","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neuropharm.2020.107995_bib70","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2788.2007.00955.x","article-title":"Intellectual abilities in a large sample of children with Velo\u2013Cardio\u2013Facial Syndrome: an update","volume":"51","author":"Smedt","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.neuropharm.2020.107995_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2018.05.015","article-title":"The predictive coding account of psychosis","author":"Sterzer","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib72","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J. Exp. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107995_bib73","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jmg.34.6.453","article-title":"Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS","volume":"34","author":"Swillen","year":"1997","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2020.107995_bib74","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ajmg.c.31435","article-title":"Developmental trajectories in 22q11.2 deletion","volume":"169","author":"Swillen","year":"2015","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.neuropharm.2020.107995_bib75","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/DBP.0000000000000210","article-title":"Behavioral and psychiatric phenotypes in 22q11.2 deletion syndrome","volume":"36","author":"Tang","year":"2015","journal-title":"J. Dev. Behav. Pediatr. JDBP"},{"key":"10.1016\/j.neuropharm.2020.107995_bib76","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamapsychiatry.2014.2671","article-title":"Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome","volume":"72","author":"Vorstman","year":"2015","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107995_bib77","series-title":"Wechsler Adult Intelligence Scale\u20144th Edition (WAIS-4)","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.neuropharm.2020.107995_bib78","series-title":"The Wechsler Intelligence Scale for Children\u2014Fourth Edition","author":"Wechsler","year":"2004"},{"key":"10.1016\/j.neuropharm.2020.107995_bib79","series-title":"Wechsler Adult Intelligence Scale\u20143rd Edition (WAIS-3)","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.neuropharm.2020.107995_bib80","series-title":"The Wechsler Intelligence Scale for Children\u2014Third Edition","author":"Wechsler","year":"1991"},{"key":"10.1016\/j.neuropharm.2020.107995_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.plefa.2014.04.004","article-title":"Effect of supplementation with long-chain \u03c9-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit\/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial","volume":"91","author":"Widenhorn-M\u00fcller","year":"2014","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.neuropharm.2020.107995_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.conb.2007.03.009","article-title":"Emotional and cognitive changes during adolescence","volume":"17","author":"Yurgelun-Todd","year":"2007","journal-title":"Curr. Opin. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:36:48Z","timestamp":1777426608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820300617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":82,"alternative-id":["S0028390820300617"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107995","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107995"}}